Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin von Dujovne, Carlos A., Chremos, A.N., Pool, James L., Schnaper, Harold, Bradford, Reagan H., Shear, Charles L., Higgins, Jim, Downton, Maria, Franklin, Frank A., Nash, David T., Gould, A.Lawrence, Langendörfer, Alexandra

Volltext

Famotidine, a New, Potent, Long-Acting Histamine H2-Receptor Antagonist: Comparison With Cimetidine and Ranitidine in the Treatment of Zollinger-Ellison Syndrome von Howard, J.M., Chremos, A.N., Collen, M.J., Mcarthur, K.E., Cherner, J.A., Maton, P.N., Ciarleglio, C.A., Cornelius, M.J., Gardner, J.D., Jensen, R.T.

Volltext

Pharmacodynamics of famotidine in humans von Chremos, A.N.

Volltext

Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia von Bradford, Reagan H., Shear, Charles L., Chremos, A.N., Franklin, Frank A., Nash, David T., Hurley, Dennis P., Dujovne, Carlos A., Pool, James L., Schnaper, Harold, Hesney, Michael, Langendörfer, Alexandra

Volltext

Comparison of effects of oral and intravenous famotidine on inhibition of nocturnal gastric acid secretion von Ryan, Jerome R., Vargas, Ramon, McMahon, F.Gilbert, Chremos, A.N.

Volltext

Body weight and blood lipid levels in obese subjects treated with fenfluramine (N-ethyl-3-trifluro-methylphenethylamine) von Chremos, A.N., Dannenburg, W.N. & Noble, R.E.

Volltext

Time‐Dependent Change in Renal Clearance of Bethanidine in Humans von Chremos, A.N., Shen, D., Gibaldi, M., Proctor, J.D., Newman, J.H.

Volltext

Clinical Evaluation of Sublingual Nitrates: Onset and Duration of Action of Nitroglycerin and Isosorbide Dinitrate von Bunn, William H., Chremos, A.N.

Volltext